Can you imagine a world in which antibiotics are no longer effective and diseases that we now consider treatable become deadly again? Well, this scenario is not science fiction, but a real threat we face due to antimicrobial resistance (AMR). Combating it requires much more than new medicines: it is a social, political and global challenge that demands innovative solutions and cross-sectoral collaboration.
Just a few months ago, the Journal of European Public Policy published the article “Beyond medicine: antimicrobial resistance (AMR) as a social and political challenge that can be overcome”. This paper approaches antibiotic resistance from a perspective that goes far beyond the purely medical field, highlighting the influence of social norms, public policies and governance structures on the use of antimicrobials and, consequently, on the spread of resistance.
At HIFAS Biologics we could not agree more with this approach. The fight against antimicrobial resistance is not exclusive to the medical community, but requires joint action between different sectors: governmental, academic, business and social.
AMR: A problem that transcends medicine
The indiscriminate use of antibiotics and other antimicrobials has led to the development of resistant microorganisms, compromising the efficacy of treatments and threatening to generate an unprecedented health crisis. However, reducing the problem to a matter of medical prescription would be a mistake.
The article published in the Journal of European Public Policy highlights the importance of social and political factors in the management of antimicrobial resistance. Cultural norms around drug consumption, government regulation of drug distribution and investment in research and development are key elements in controlling this problem.
Innovation and commitment in the fight against AMR
At HIFAS Biologics, we are committed to developing innovative solutions that help fight the most resistant infections. Through our research in fungal-based medicines, we seek therapeutic alternatives that reduce reliance on traditional antibiotics and provide new strategies to tackle AMR.
Fungi have proven to be a promising source of compounds with antimicrobial properties. Their biochemical diversity allows us to explore new avenues to combat infections without fostering the development of resistance. By combining our scientific knowledge with a multidisciplinary approach, we are working to provide effective tools in the fight against this crisis.
The importance of cross-sectoral collaboration
The main message of the article is clear: only through cross-sectoral collaboration can we overcome the challenge of AMR. Effective regulation of antimicrobials, support for research into new therapies and public education on the responsible use of these drugs are essential to turn the tide of this crisis.
From HIFAS Biologics, we call on all the actors involved: governments, academic institutions, biotech companies and society in general. It is time to join efforts, share knowledge and develop sustainable strategies to ensure a healthier future for all.